![Anti-Progesterone Receptor (A/B Forms) antibody [16+SAN27] (STJ16101785)](https://cdn11.bigcommerce.com/s-zso2xnchw9/images/stencil/124x110/products/152291/347138/STJ16101785_1__65460.1681999409.jpg?c=1 "Anti-Progesterone Receptor (A/B Forms) antibody [16+SAN27] (STJ16101785)")
![Anti-Progesterone Receptor (A/B Forms) antibody [16+SAN27] (STJ16101785)](https://cdn11.bigcommerce.com/s-zso2xnchw9/images/stencil/1280x1280/products/152291/347138/STJ16101785_1__65460.1681999409.jpg?c=1 "Anti-Progesterone Receptor (A/B Forms) antibody [16+SAN27] (STJ16101785)")
Anti-Progesterone Receptor (A/B Forms) antibody [16+SAN27] (STJ16101785)
SPECIFICATIONS
ClonalityMonoclonal
HostMouse
ConjugationUnconjugated
IsotypeIgG1
ImmunogenProkaryotic recombinant protein corresponding to the N-terminal region of the A form of the human progesterone receptor generating clone 16 and a prokaryotic recombinant protein corresponding to the 164 amino acid N-terminal region unique to the B fo
General Information
| Short Description | Mouse monoclonal anti-Progesterone Receptor (A/B Forms) for use in IHC-P in Human samples. Datasheet included with dilution recommendations, and related reagents. |
| Applications | IHC-P |
| Host | Mouse |
| Reactivity | Human |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Clonality | Monoclonal |
| Clone ID | 16+SAN27 |
| Isotype | IgG1 |
| Conjugation | Unconjugated |
| Formulation | Tissue culture supernatant with sodium azide |
| Storage Instruction | Store at 2-8°C for up to 1-year, upon receipt. |
Target Information
| Immunogen | Prokaryotic recombinant protein corresponding to the N-terminal region of the A form of the human progesterone receptor generating clone 16 and a prokaryotic recombinant protein corresponding to the 164 amino acid N-terminal region unique to the B fo |
Additional Info
| Background | The human progesterone receptor (PR) is expressed as two isoforms, PRA (94 kD) and PRB (114 kD) , which function as ligand-activated transcription factors. In vitro studies have indicated that PRA and PRB can activate different target genes and that PRA, in some circumstances, may act as a dominant inhibitor of the function of PRB and other steroid hormone receptors. PRA and PRB are both expressed in normal breast. Most endometrial carcinomas, however, are reported to express only one isoform with either PRA or PRB being expressed. The cocktail has been formulated using two clones, clone 16, specific for PRA, and SAN27, specific for PRB. |
Information sourced from Uniprot.org